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An atlas of combinatorial transcriptional regulation in mouse and
man
The FANTOM consortium and RIKEN Omics Science Center
SUMMARY
Combinatorial interactions among transcription factors are critical to directing tissue-specific gene
expression. To build a global atlas of these combinations, we have screened for physical interactions
among the majority of human and mouse DNA-binding transcription factors (TFs). The complete
networks contain 762 human and 877 mouse interactions. Analysis of the networks reveals that highly
connected TFs are broadly expressed across tissues, and that roughly half of the measured interactions
are conserved between mouse and human. The data highlight the importance of TF combinations for
determining cell fate, and they lead to the identification of a SMAD3/FLI1 complex expressed during
development of immunity. The availability of large TF combinatorial networks in both human and
mouse will provide many opportunities to study gene regulation, tissue differentiation, and
mammalian evolution.
INTRODUCTION
Tissue specificity is enabled by spatial and temporal patterns of gene expression which, in turn,
are driven by transcriptional regulatory networks (Naef and Huelsken, 2005; Zhang et al.,
2004). Such networks involve assemblies of control proteins, such as DNA-binding
transcription factors (TFs), connected to the sets of promoters of genes they induce or repress
(Tan et al., 2008b). Typically, TFs do not act independently, but form complexes with other
TFs, chromatin modifiers, and co-factor proteins, which bind together and assemble upon the
regulatory regions of DNA to affect transcription (Fedorova and Zink, 2008). Mapping the
combinatorial interactions among TFs would represent a significant leap forward in our
understanding of how tissue specificity is determined.
In recent years, a variety of genome-scale technologies have been introduced which allow
mammalian transcriptional regulatory networks to be investigated at high resolution and depth.
Many such studies have inferred transcriptional networks through mRNA expression profiling
combined with genome-wide active promoter mapping and promoter motif analysis (Suzuki
et al., 2009). These data have been supplemented with Fluorescence Activated Cell Sorting
(FACS) (Shachaf et al., 2008) or Reverse Transcriptase Quantitative Polymerase Chain
Reaction (qRT-PCR) (Roach et al., 2007; Wen et al., 1998).
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Another technology that has revolutionized the study of transcriptional networks is Chromatin
Immuno-Precipitation (ChIP) which, when coupled with microarrays or high-throughput
sequencing (Johnson et al., 2007), enables genome-wide measurements of TF binding locations
in vivo. A complementary approach is the Protein Binding Microarray (PBM) (Berger et al.,
2008), which rapidly characterizes the complete DNA sequence repertoire bound by a TF in
vitro. ChIP and PBMs have been applied to map transcriptional networks in a variety of human
cell types, including stem cells (Cole et al., 2008; Lee et al., 2006) and lymphocytes (Marson
et al., 2007; Schreiber et al., 2006), and to characterize the binding motifs of many mammalian
TF families (Berger et al., 2008).
Although these studies have led to the construction of very large models of transcriptional
networks, they are based on experiments that largely treat each TF in isolation: for instance,
ChIP-chip measures binding locations for one TF at a time, although separate profiles for
several TFs can be later combined into networks (Mathur et al., 2008). However, it is well
known that the transcriptional output of a gene is due to the joint activity of many TFs whose
binding and activation are highly interdependent. This cooperativity is often mediated by direct
physical contact between two or more TFs, forming homodimers, heterodimers, or larger
transcriptional complexes. In fact, it has been estimated that approximately 75% of all
metazoan TFs heterodimerize with other factors (Walhout, 2006). Newman and Keating used
protein arrays to reveal a network of several hundred domain interactions among the bZIP TF
family alone (Grigoryan et al., 2009). Other studies have successfully assembled large
networks of protein interactions using technologies such as co-immunoprecipitation and two-
hybrid screening (Park et al., 2005; Yu et al., 2008), but to date these have not been
systematically applied to map networks of transcription factors. Thus, a clear and immediate
task is to map which combinations of TFs act together, and how these combinations lead to
modes of regulation that are not evident when each factor is considered separately.
Towards this goal, we have pursued an integrative approach to systematically map
combinatorial interactions among mammalian TFs. Our approach draws from two systems-
wide data sets generated in both human and mouse: Physical protein-protein interaction among
TFs measured using the Mammalian Two Hybrid (M2H) system, and quantitative TF
expression levels measured using qRT-PCR across tissues. Analysis of these data identifies a
database of TF complexes and networks, which can be used to elucidate the regulatory
programs behind developmental processes and disease. Chief among these results is a network
of homeobox TFs which we show can predict tissue type in mammals.
RESULTS
Mammalian transcription factor protein-protein interaction networks
We compiled a list of 1988 human and 1727 mouse DNA-binding transcription factors using
information from public gene databases (Supplementary Table 1). Of these, 1222 and 1112
cDNA clones were captured in human and mouse, respectively, that could be verified to express
full-length protein (Supplementary Table 1). All pair-wise combinations of TF cDNAs were
systematically screened for protein-protein interaction using the M2H system (Suzuki et al.,
2001). Bait and prey constructs were co-transfected in CHO-K1 cells, and the interaction of
the expressed proteins was monitored by luciferase reporter activity. This process identified
762 and 877 high-stringency TF-TF interactions in human and mouse, respectively
(Supplementary Tables 2,3). The use of M2H meant that the human and mouse TF interactions
were measured in near-physiological conditions including mammalian post-translational and
other modifications. The web-accessible atlas of all pairwise TF interactions mapped by M2H
is available at http://fantom.gsc.riken.jp/4/tf-ppi. This resource is searchable by gene ID or
function and provides network visualizations as well as raw lists of interactions.
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To estimate the sensitivity of the screening approach (the percentage of all true TF-TF
interactions that are identifiable by M2H), we assembled a gold-standard set of high confidence
TF-TF dimers reported in previous literature. To obtain this gold standard, a set of 289 mouse
TF-TF interactions were downloaded from public databases and further curated to select 91
interactions supported by two or more independent lines of evidence or primary experimental
reports (Supplementary Information and Supplementary Table 3). We found that M2H
recovered protein-protein interactions for 23 of these heterodimers, yielding a sensitivity of
25%. Apart from sensitivity we were also interested in precision (the percentage of reported
interactions that are true, equal to 1 – false discovery rate). Precision is more difficult to estimate
than sensitivity, because it requires a gold standard that contains not only known interactions
but also a large number of protein pairs that are known to be non-interacting. Since such data
are not available, we sought to confirm the M2H positives using in-vitro pull down assays as
a second technology. Of 34 randomly chosen mouse M2H positives, 18 (53%) were detected
by in-vitro pull down (Supplementary Table 4). This second assay is not a gold standard, such
that failure to confirm an M2H positive by in-vitro pull down does not negate the corresponding
protein-protein interaction, which might be transient or unstable under conditions of the pull-
down. However, this analysis does show that the M2H network recovers approximately one
quarter of known TF heterodimers and that the majority of M2H interactions can be replicated
by a second technology. These figures are consistent with high quality interaction networks
published recently elsewhere (Yu et al., 2008).
We now describe four case studies that use the atlas to address questions of how transcriptional
control contributes to tissue specificity in mammals. These case studies cover: (1) Integration
of the atlas with quantitative TF abundance levels across human and mouse tissues, revealing
a prominent relationship between TF connectivity and expression— (2) Identification of a
subnetwork of homeobox factors that is highly discriminative and predictive of tissue type—
(3) A proteome-wide map of conserved transcriptional complexes in mammals, many of which
have tissue-specific expression patterns that are also highly conserved— and (4) Examples of
how the atlas can be used to recognize and further explore TF heterodimers in control of tissue
differentiation.
Integration of TF interaction and expression reveals insights into network structure
In order to physically interact, TFs must be co-expressed in the same tissue or cell type. To
investigate the tissue specificity of TF interactions, we obtained quantitative mRNA profiles
of all TFs using qRT-PCR across a panel of 34 human and 20 mouse tissues (Supplementary
Table 5). For each TF we computed a Tissue Specificity Score (TSPS), which uses relative
entropy to quantify the extent to which the observed TF expression pattern departs from the
null distribution of uniform expression across all tissues (Experimental Procedures,
Supplementary Tables 1,5). Examination of tissue specificity over all TFs suggested a mixture
of two distinct TF populations, with one population of TFs having widespread tissue expression
(TSPS < 1) and a second smaller population at higher tissue specificity (TSPS ≥ 1, Figures
1A–B). We called TFs with widespread expression “facilitators”, based on the hypothesis that
they facilitate transcriptional programs across many different tissues, and those with high
specificity tissue “specifiers”. For example, the TFs JUN and FOS, which form the AP-1
heterodimer, were classified as strong facilitators owing to low TSPS (average around 0.6,
Supplementary Table 5). This score is consistent with the classical view of AP-1 as a broad
activator of expression in major cellular processes including differentiation, proliferation, and
apoptosis (Ameyar et al., 2003). In contrast, many TFs with known roles in tissue
differentiation were classified as “specifiers”, such as MYOD1, which regulates muscle
development and members of the Paired box (Pax) TF family involved in tissue morphogenesis.
The observed bimodal distribution of TF expression is in agreement with recent findings from
a meta-analysis of publicly-available expression profiles in humans (Vaquerizas et al., 2009).
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Examining the relationship between expression and interaction, we observed a strongly
negative Pearson correlation of −0.79 between a TF’s number of protein interactions and its
TSPS. That is, we found that TFs with few interactions tend to be expressed in a tissue-specific
pattern while TFs with many interactions—so called network “hubs” (Jin et al., 2007; Yu et
al., 2006)— tend to be expressed across many tissues (Figure 1C). The observed correlation
was highly significant, as assessed by 10,000 random trials in which the assignment of
expression values to TFs was permuted (r = 0.00 ± 0.03). Such widespread expression of TF
hubs bears some similarity to previous studies of TF-DNA (transcriptional) interactions, in
which the number of promoters bound by a TF was found to correlate with the number of
growth conditions in which it is expressed (Luscombe et al., 2004; Zhou et al., 2008).
A homeobox network associated with specification of tissue type
Combinatorial interaction among transcription factors is critical for differentiation of tissues
(Davidson et al., 2002). To identify TF interaction networks involved in tissue development,
we clustered the TF expression profiles across the 34 human tissues (see above) using two
approaches: a basic tissue separation approach using expression levels only, and a “network-
transformed” approach in which we exploited as features the differences in expression level
across TF-TF interactions, as suggested by a recent study (Taylor et al., 2009). We found that
network transformation resulted in an increased separation of tissues into four well-formed
clusters (a 38% increase, Figures 2A,B and Supplementary Figure 1). These corresponded to
well-defined tissue classes according to embryonic origin: ectoderm (including Central
Nervous System or CNS), mesoderm, endoderm, and cell lines. Strikingly, only six TF
interactions were sufficient to classify tissue type with a high accuracy of 82% (Figures 2B,C).
Moreover, we found that these interactions fell into the same small network neighborhood
defined by a subnetwork of 15 proteins (Figure 2C). This subnetwork was highly enriched for
homeobox factors (7/15 proteins) many of which have, at least individually, known roles in
tissue type specification during development (Duverger and Morasso, 2008). Although we
expected that many of these TFs would be tissue specifiers, we found that 10 of the 15 were
in fact facilitators expressed broadly across most tissue types. These results support the notion
that it is the interactions among transcription factors, more than their expression levels alone
that help to determine tissue identity.
Given the ability of the homeobox-related subnetwork to separate tissues based on their
embryological origin, we sought to test whether this subnetwork was also able to discriminate
the embryological origin of different types of stem cells. Understanding the transcriptional
events that commit stem cells to different tissue lineages is one of the major goals of stem cell
research (Jaenisch, 2009). For this purpose, we downloaded the publicly-available gene
expression profiles of 219 stem cell lines derived from a variety of different tissue types (Muller
et al., 2008) (Supplementary Table 6 lists the tissue origin of each cell line). As shown in
Figures 2D–E, the homeobox-related subnetwork was indeed able to separate these stem cell
expression profiles by ectoderm, mesoderm, and endoderm origin. This separation was 33%
better than that achieved using other methods (Figure 2D). This analysis suggests that the good
performance of the homeobox-related subnetwork (Figure 2C) is not the result of overfitting
to a specific set of tissue expression profiles. Moreover, it provides further evidence that the
combinatorial interactions revealed in this subnetwork play an important role in cell
commitment to different tissue lineages.
Conservation of TF complexes across mammalian evolution
A strong line of evidence that a particular TF interaction is functional is to observe conservation
of that interaction across species. For each human TF, we used the InParanoid algorithm
(O’Brien et al., 2005) to identify its set of amino-acid sequence orthologs in mouse. We then
identified pairs of TFs for which the orthologs were observed to interact in both species. In
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total, 80 conserved interactions were identified between the M2H data of human and mouse
—this number rose to 305 conserved interactions when supplementing M2H data with literature
(Supplementary Tables 2,3). Considering this number together with the M2H sensitivity and
precision estimates above, we computed the fraction of conserved TF-TF interactions between
human and mouse to be in the range of 34 – 64% (depending on the value one uses for the
precision of M2H screening, see Supplementary Information).
We next used NetworkBLAST (Kalaev et al., 2008) to examine how these conserved
interactions clustered within the network, i.e. whether they fell within common subnetworks
suggestive of conserved transcriptional complexes. In total, 68 conserved complexes were
identified which contained approximately six TFs on average. Examples of conserved
complexes are shown in Figures 3A–F; the complete set is included as part of the atlas at
http://fantom.gsc.riken.jp/4/tf-ppi. Eighty percent of the conserved complexes were enriched
for Gene Ontology Biological Process annotations. These conserved TF complexes provide a
first-draft map of the combinatorial regulatory circuits common to mammals.
The conserved complexes also suggest combinations of heterodimers in specific biological
contexts for future investigation. Figure 3C shows a conserved complex of six TFs, in which
five are broadly expressed across all tissues in both species, and one TF (LHX2) is restricted
to frontal cortex also in both species (Supplementary Table 5). Figures 3D–F show three
conserved TF complexes consisting of proteins co-expressed in cerebellum. Messenger RNA
in-situ hybridization analysis of mouse cerebellum, obtained from the Allen Brain Atlas (Lein
et al., 2007), confirms that the interacting TFs are indeed expressed in cerebellum and that this
localization is cerebellum-specific at single-cell resolution.
FLI1 and SMAD3 form a heterodimeric complex associated with monocyte development
The vast majority of TF-TF interactions recorded in the atlas represent new combinations not
yet documented in the literature. Thus, an important question is how particular interactions of
interest should be carried forward in the laboratory to identify new transcriptional heterodimers
and to study their regulatory functions. As an example use of the atlas to identify tissue-
restricted heterodimers, four interactions were selected for which at least one TF had moderate
to high tissue specificity (Figure 4A). For example, Peroxisome Proliferator-Activated
Receptor Gamma (PPARG) is expressed in adipose, skin, lung, and breast, with little or no
expression in other tissues. Although its interaction partner, Retinoid X Receptor Beta (RXRB),
is expressed ubiquitously the interaction requires the presence of both TFs and thus remains
tissue restricted (Supplementary Table 5).
Given these tissue-restricted TF combinations, a first step was to characterize and further
establish their physical interaction. We used bidirectional in-vitro pull-down assays to examine
whether each TF pair could exhibit strong, stable, and direct physical binding under the
conditions of the pull-down, independent of other proteins or factors. As shown in Figure 4B,
all four TF interactions were recapitulated as in-vitro pull-downs, making them strong
candidates for functional transcriptional complexes.
Next, we sought detailed information on the dynamic expression of a TF combination in the
tissue(s) in which both TFs were active. One of the identified TF interactions was between
Friend Leukemia virus Integration 1 (FLI1) and SMAD family member 3 (SMAD3), in which
FLI1 was restricted primarily to macrophage-related tissues (THP-1, spleen, lymph) while
SMAD3 was found to be expressed more generally (Figure 4A and Supplementary Table 5).
Thus, we investigated the role of the FLI1/SMAD3 interaction in macrophage differentiation,
using qRT-PCR to record a time-course of expression of both TFs during differentiation of
THP-1 monoblasts to monocytes following stimulation by PMA. Strikingly, both TFs were
coordinately down-regulated at early time points during differentiation (Figure 4C). These data
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are supported by previous findings, in which SMAD3 has been shown to regulate cell
proliferation through TGF-β1 signaling (Meran et al., 2008), and FLI1 has been shown to re-
activate NOTCH pathways resulting in p53-dependent cell cycle arrest (Ban et al., 2008). A
hypothesis for future work is that FLI1/SMAD3 may function together as a repressor complex
that controls cell proliferation during differentiation (Figure 4D).
DISCUSSION
In this study, we have mapped an atlas of combinatorial interactions among the majority of
human and mouse TFs. This work makes available a number of significant resources for the
biomedical community, including a database of over 1,600 human or mouse TF-TF interactions
(Supplementary Tables 2,3) and quantitative TF expression measurements across human and
mouse tissues (Supplementary Table 5). The data highlight conserved TF subnetworks whose
patterns of interaction and tissue specificity suggest transcriptional complexes in control of
tissue identity.
Our analysis, derived by the integration of these datasets, supports a model whereby the
transcriptional network structure is dominated by facilitator TFs expressed broadly across
tissues (Figure 1 and Supplementary Table 1). The implication is that tissue identity is not
determined by tissue-restricted TFs, but relies on tissue-restricted interaction among TFs. Each
TF may be expressed in a variety of tissues, but it is only where two TFs are co-expressed and
co-localized that an interaction, and its functional consequences, may occur. In this model,
tissues restricted TFs (specifiers) tend to interact with TFs that are broadly-expressed (Figure
1), increasing the number of possible combinatorial events only in certain tissues or during
tightly-regulated developmental processes. In support of this interaction-centric model, we
identified a subnetwork of just 15 TFs that was sufficient to confer maximal separation of
tissues and stem cell lines into the three germ layers associated with embryogenesis (Figure
2). This network significantly outperformed tissue separation based on the expression of
individual factors alone. Two thirds of these “germ layer” factors were facilitator TFs expressed
in the majority of tissues. .
The theme of “specificity through interaction” is also evident among the conserved TF
subnetworks (Figure 3). The majority of TFs in these networks are broadly expressed, and it
is the minority of TFs that confer tissue specificity. Further evidence comes from the four
identified TF complexes we validated and placed into biological contexts (Figure 4 and
Supplementary Table 5). Although they were not selected on this basis, at least three of these
complexes involve combination of a tissue restricted TF (i.e., NR3C1, PPARG, FLI1) with a
partner whose expression pattern is more widespread (RXRB, RXRB, SMAD3).
The availability of large TF-TF combinatorial interaction networks in both human and mouse
will provide many opportunities to study network conservation and divergence over the course
of mammalian evolution. Debate is still ongoing regarding the rate at which various types of
molecular networks evolve. Here, we found that conservation between human and mouse TF-
TF interactions was moderate (Figure 3), in the range of 34 to 64 percent. In contrast, a recent
comparison of transcriptional (protein-DNA) interactions reported that this type of network is
highly divergent over even very short evolutionary timescales (Tuch et al., 2008). A
comparison of genetic networks (synthetic lethal and epistatic interactions) also found extreme
rates of divergence (Roguev et al., 2008). On the other hand, protein-protein interactions,
especially those that form major structural and functional components of the eukaryotic cell,
were found to be highly conserved (Tan et al., 2008a). Protein-protein interactions forming
transcriptional complexes, as we have studied here, appear to be conserved at an intermediate
level somewhere between the extremes. That is, TF-TF complexes are likely more mutable
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than the major complexes of cell structure and central metabolism, but much less so than the
rapid rewiring that appears to take place in networks of transcription factor/promoter binding.
It has long been appreciated that gene regulation involves combinatorial interactions among
transcription factors. The contribution of the present work is to map, on a global scale, precisely
what many of these connections are. With few exceptions, almost all of the uncovered
connections are undocumented in the existing literature. Future work will dissect more
precisely how each of these combinations contributes to developmental programs and to an
individual’s relative state of health or disease.
EXPERIMENTAL PROCEDURES
Mammalian two-hybrid assays
Following PCR amplification of full-length TFs, M2H was carried out as previously described
(Usui et al., 2005). To assess potential for self-activation each BIND TF fragment (bait) was
transfected into CHO-K1 cells containing the luciferase reporter plasmid pG5luc. Reporter
activity was measured after 20h and BIND samples with high self-activation (more than 5-fold
larger than average) were removed. For non-self-activating baits, eight BIND TF fragments
(baits) and two ACT TF fragments (preys) were co-transfected into CHO-K1 cells with
pG5luc2, and luciferase reporter activity was measured after 20h. The screen was also
performed using two BIND TFs combined with two ACT TFs. For transfections with positive
reporter activity, the assay was repeated using all 2×2 or 8×2 BIND/ACT combinations to
identify the interacting TF pairs. Positive interactions were scored as those that showed at least
three times higher luciferase activity than background (measured using transfection of either
an ACT-TF or BIND-TF alone). For more details see Supplementary Information and
Supplementary Tables 2,3.
In vitro pull-down assay
PCR products encoding the TF coding sequence and the SV40LPAS fragment were used to
construct a template for in vitro transcription/translation. The products were combined by
overlapping PCR using the primer pair T7-RBS-KOZAK (5′-
GAGCGCGCGTAATACGACTCACTATAGGGGAAGGAGCCGCCACCATG-3′) and
LGT10L (5′-AGCAAGTTCAGCCTGGTTAAG-3′), yielding a final template encoding a 5′
T7 RNA polymerase promoter. In vitro pull-down assays were carried out as previously
described (Suzuki et al., 2004). Briefly, biotinylated or [35S]-labeled TF was synthesized in
vitro from the template using Transcend™ Biotinylated lysine-tRNA (Promega) or Redivue L-
[35S]-methionine (Amersham Biosciences) in combination with the TNT T7 Quick Coupled
Transcription/Translation System (Promega). After confirmation of [35S]-labeled protein
synthesis by SDS–PAGE and autoradiography, biotinylated protein and [35S]-labeled protein
were mixed 1:1 and incubated on ice for one hour. Control reactions containing [35S]-labeled
protein alone were conducted in parallel. The reaction was then incubated with streptavidin
Dynabeads (Dynal Biotech, Milwaukee, WI) for 30 min at 4°C on a rotary shaker. Dynabeads
were isolated with a magnet and washed 5 times with ice-cold TBST buffer (50 mM Tris-HCl
pH 8.0, 137 mM NaCl, 2.68 mM KCl, 0.1% Tween 20). The amount of radio-labeled protein
co-precipitated with the biotinylated protein was measured by scintillation counting or was
detected by SDS-PAGE. The ratio of scintillations with and without biotinylated protein was
calculated to measure the interaction between the two proteins (Supplementary Table 4).
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Tissue specificity score (TSPS)
The value , the fractional expression level of TF i in tissue j, was computed as the ratio of
the TF expression level in tissue j (qRT-PCR) to its sum total expression level across all tissues.
Tissue specificity TSPSi was then computed using relative entropy:
where qi is the fractional expression of TFi under a null model assuming uniform expression
across tissues. According to this definition, a minimal TSPS = 0 would be reported for TFs
expressed uniformly across all tissues, while a maximal TSPS ≌ 5 would be reported for TFs
expressed only in a single tissue. The threshold chosen for classifying TFs as tissue
“specifiers” (TSPS ≥ 1) was based on the observed bimodal distribution of expression over all
TFs and tissues (Figure 1A). This threshold is conservative, as it selects TFs with roughly a
20-fold expression difference or greater across tissues (Supplementary Tables 1 and 5).
Unsupervised tissue separation
Two different feature sets were considered for tissue separation: (1) TF expression values and
(2) TF-TF interaction values. For both feature sets the raw qRT-PCR expression values were
normalized so that each tissue had the same average value over all TFs, then log transformed
(Supplementary Tables 1,5). Following (Taylor et al., 2009) interaction values were computed
for each interaction between a hub and any other TF, with hubs taken as TFs with > 12
interactions (Figure 1C Supplementary and Tables 2,3). Separations were performed using a
hybrid two-phase procedure. The first phase was non-centered Principal Components Analysis
(ncPCA), in which the second principal component resulting from this analysis (PC2) was
found to be the main direction informative for tissue separation (either feature set). The features
were then ranked according to their absolute PC2 loadings and a second phase of
dimensionality reduction was performed using the ranked features. For this second phase, non-
centered Kernel PCA (ncKPCA) was used with two parameters: (1) the standard deviation of
the Gaussian kernel and (2) the number of top-ranked features selected for separation.
Performance of separation into the tissue classes was measured by the Bezdek cluster validity
index (CVI) considering the first two dimensions (PC1, PC2). Further details are provided in
Supplementary Information.
We also examined the dependence of tissue specification on the particular network used.
Although the M2H network reported here (Supplementary Tables 2,3) is the first large-scale
experimental screen for TF-TF interactions, previous studies have sought to predict relevant
TF combinations based on co-occurrence of TF binding sites within gene promoters (Yu et al.,
2006). However, we found that a network of TF pairs predicted using binding site co-
occurrence did not perform as well as the network of physical TF interactions elucidated by
M2H and previous literature (Figure 2A). We also found that the performance of network-
based tissue specification was not dependent on the particular algorithm used for separation.
Both ncKPCA and Sammon Mapping approaches yielded very similar performance with
Cluster Validity Index (CVI) ≌ 1, and in both cases CVI was maximized for exactly six
interactions (Figure 2F).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. TF expression versus connectivity
(A) Distribution of tissue specificity for all TFs. The green curves fit the bi-modal distribution
as a mixture of two Gaussian. (B) Scatterplot of tissue specificity (y-axis) versus number of
neighbors (x-axis). Red points are defined as specifier hubs and blue points as facilitator hubs
(Supplementary Table 1). (C) TFs are binned into four groups of approximately equal size
based on their number of interactions (x-axis). The tissue specificity distribution of each bin
is represented by stacks of colored segments. Segment height represents the fraction of TFs in
an expression group (left y-axis), and segment color represents the number of tissues in which
TFs in that group are expressed. The black line displays the median TSPS of each group (right
y-axis). Among TFs with six or more interactions, 70% are expressed in more than half of
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tissues. Among TFs with fewer than six interactions, this number falls to 45%. The results
shown are for human M2H interactions supplemented with TF-TF interactions downloaded
from literature (Supplementary Table 2); similar results are obtained for mouse interactions or
for M2H interactions only (Supplementary Table 3. See also Supplementary Table 4 for
confirmation of the M2H positives using in-vitro pull down assays as a second technology).
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Figure 2. A homeobox network associated with tissue differentiation
(A) Performance of tissue separation with (green solid curve) or without (black solid curve)
information about TF protein-protein interactions (Supplementary Table 2). The Bezdek
cluster validity index (CVI, y-axis) is a measure of separation between the four tissue classes.
CVI is plotted for increasing kernel standard deviation (x-axis), the only tuning parameter of
the ncKPCA algorithm used for tissue separation. Performance was also evaluated for TF pairs
predicted to cooperate based on co-occurrence of TF binding sites (yellow curve) (Yu et al.,
2006) as well as for random features (dashed curves). (B) Tissue dimensionality reduction by
ncKPCA into the first two Principle Components (PCs), considering features derived from the
six most informative TF-TF interactions. Points represent tissues derived from ectoderm
(green), mesoderm (yellow), or endoderm (red), or a monocyte cell line (blue). Gray circles
denote four clusters obtained by affinity propagation in the (PC1, PC2) space, with each point
connected to its cluster exemplar. This figure is related to Figure S1. (C) Informative
subnetwork containing six interactions (green) used to generate features for tissue separation.
Also shown are the immediate network neighbors of the interacting TFs. (D) CVI for the
separation of stem cells (Supplementary Table 6) using Sammon Mapping. Four feature sets
are shown: the original expression values from Muller et al, the expression of the TFs only,
the entire set of TF protein-protein interactions, or the features corresponding to the six
interactions in panel C (5* indicates that the interaction HOXA9-MEIS1 was not considered
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because HOXA9 expression was not measured in the stem cell investigation of Muller et al).
(E) Stem cell dimensionality reduction obtained by Sammon Mapping using the panel C
interaction set. Points represent stem cell lines derived from ectoderm (green), mesoderm
(yellow), or endoderm (red). (F) Good performance of tissue separation observed with two
different algorithms. ncKPCA (green curve) and Sammon Mapping (blue curve). CVI (y-axis)
is plotted against the number of PC2-ranked interactions used to separate tissues (x-axis). In
both cases, the maximum performance is observed using the first six PC2-ranked interactions
to separate tissues.
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Figure 3. TF subnetworks conserved across human and mouse
(A–F) Examples of TF subnetworks conserved in specific tissues. Human proteins are circles
and mouse proteins are diamonds, colored in increasing shades of red representing increasing
tissue specificity (TSPS), (Supplementary Table 1). Stars indicate hubs. Horizontal dashed
links indicate protein orthology relationships across species, whereas solid links indicate
protein-protein interactions within species (red links are newly-discovered, black links are
literature-curated). (E–F) Conserved TF subnetworks that are specific to cerebellum, as first
indicated by qRT-PCR (red nodes and Supplementary Table 5) and subsequently confirmed
by in-situ hybridization to mouse brain tissue samples. All conserved subnetworks are available
at http://fantom.gsc.riken.jp/4/tf-ppi.
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Figure 4. Physical and functional exploration of tissue-restricted heterodimers
(A) Four heterodimers that display combinatorial logic across tissues. The heatmap shows the
mRNA copy number of each heterodimeric TF across tissues measured by qRT-PCR
(Supplementary Table 5). (B) In-vitro pull down experiment shows clear bi-directional
physical interaction for each of the four heterodimers as detected originally by M2H assay
(Supplementary Table 2). (C) mRNA levels of FLI1 and SMAD3 during THP-1 differentiation
induced by PMA, as measured by qRT-PCR. (D) Graphical representation of FLI1/SMAD3
control during myeloid differentiation.
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